The specific objectives of this funding opportunity are to:

• Generate new data and evidence relating to the therapeutic efficacy and safety of psilocybin-assisted psychotherapy for substance use and mental health disorders;
• Facilitate consideration and application of new evidence to inform ongoing and future development of policies, practices and programs related to psilocybin-assisted psychotherapy;
• Strengthen research excellence and ensure maximum research impact through consideration of diverse biological and/or socio-cultural identity factors in research design, and diverse research methods such as those based in Indigenous ways of knowing.

The FY22 Defense Appropriations Act provides funding for the Pancreatic Cancer Research Program (PCARP) to support research of exceptional scientific merit and innovation with high impact that focuses on pancreatic cancer.  The managing agent for the anticipated program announcements/funding opportunities is the CDMRP at the U.S. Army Medical Research and Development Command (USAMRDC).

The FY22 PCARP funding opportunity announcements for the following award mechanisms are posted on the Grants.gov website. 

Applications submitted to the FY22 PCARP must address one or more of the following Focus Areas:

• Early detection research for pancreatic cancer, including the prevalence in individuals with pre-diabetes and diabetes and/or those in underserved ethnic and minority communities
• Supportive care interventions, patient-reported outcomes, quality of life, and perspectives during treatment and survivorship
• Understanding the relationship between metabolic disruptions in pancreatic cancer and their systemic effects, including diabetes and cachexia
• Understanding precursors, origins, and early progression of pancreatic cancer
• Understanding the events that promote pancreatic cancer metastasis
• Understanding the relationship between oncogenic signaling and the tumor microenvironment that drives drug resistance and therapeutic response
• New drug development targeted toward cancer sensitivity and resistance mechanisms including immune mechanisms of resistance

Funding Opportunities-FY22 PCARP, Congressionally Directed Medical Research Programs (CDMRP), US DoD (army.mil)

Idea Development Award – Preproposal due July 8, 2022

Established Single Principal Investigator (PI) Option:

Investigators at or above the level of Assistant Professor (or equivalent)

or

Early-Career Investigator Partnering PI Option:

Investigators at or above the level of Assistant Professor (or equivalent) may collaborate on a single application with an early-career investigator that meets the following criteria at the application submission deadline date:

• Must have instructor-level (or equivalent) faculty appointment or above
• Is no more than 10 years from the receipt of a terminal degree (excluding time spent in residency or on family medical leave) Preproposal is required; application submission is by invitation only.

• Supports new ideas that represent innovative, high-risk/high-gain approaches to pancreatic cancer research and have the potential to make an important contribution to one or more of the FY22 PCARP Focus Areas.
• Emphasis is equally placed on Innovation and Impact.
• Preliminary data are encouraged, but not required.
• Clinical trials are not allowed.
• Must address at least one of the FY22 PCARP Focus Areas.
• Early-Career Investigator Partnering PI Option supports applicants early in their faculty appointments or in the process of developing independent research careers

Translational Research Partnership Award – Preproposal due July 8, 2022

PIs must be at or above the level of Assistant Professor or equivalent.

Clinicians must be an M.D., M.D./Ph.D., or equivalent with clinical duties and/or responsibilities.

Postdoctoral and clinical fellows are not eligible.

At least one member of the partnership must have expertise either in pancreatic cancer research or pancreatic cancer patient care.

• Supports partnerships between clinicians and laboratory scientists that accelerate ideas in pancreatic cancer into clinical applications.
• Must address at least one of the FY22 PCARP Focus Areas.
• Supports translational correlative studies.
• Preliminary data required
• Retrospective tissue analysis, correlative studies, or small pilot clinical studies are permitted.

• ·        Preproposal is required; application submission is by invitation only

• Maximum funding of $750,000 for direct costs (plus indirect costs).
• Maximum period of performance is 3 years.

A pre-application is required and must be submitted through the electronic Biomedical Research Application Portal (eBRAP) at https://eBRAP.org prior to the pre-application deadline.  All applications must conform to the final funding opportunity announcements available for downloading from the Grants.gov website.  The application package containing the required forms for each award mechanism will also be found on Grants.gov.  A listing of all CDMRP and other USAMRDC extramural funding opportunities can be obtained on the Grants.gov website by performing a basic search using CFDA Number 12.420. 

For email notification when announcements are released, subscribe to program-specific news and updates under “Email Subscriptions” on the eBRAP homepage at https://eBRAP.org.  For more information about the PCARP or other CDMRP-administered programs, please visit the CDMRP website (https://cdmrp.army.mil).

Point of Contact:

CDMRP Help Desk
301-682-5507
help@eBrap.org

Please contact Jill Sherman, International Research Facilitator, at intl.research@lakeheadu.ca  for more information.

The FY22 Defense Appropriations Act is anticipated to provide funding for the Peer Reviewed Alzheimer’s Disease Research Program (PRARP) to support research that addresses the long-term implications of military service as they pertain to Alzheimer’s disease (AD) and related dementias (ADRD) for Service Members, Veterans, and the general public.  The managing agent for the anticipated program announcements/ funding opportunities is the CDMRP at the U.S. Army Medical Research and Development Command (USAMRDC).

The FY22 PRARP funding opportunity announcements for the following award mechanisms will be posted on the Grants.gov website

Applications submitted to the FY22 PRARP must address one or more of the following Focus Areas:

• Individual, caregiver, and family support:  Research and resources focused on long-term care, quality of life, psychosocial wellness and support, and community and home resources supporting aging-in-place and community living for individuals living with dementia, their families, and care partners.  Family is broadly defined to include family of choice as well.  Study population diversity is strongly encouraged.  Community-based participatory research inclusion is strongly preferred.
• Environmental, Diagnostic, and Prognostic Factors:  Research to better detect, diagnose, and predict long-term outcomes and risk factors associated with AD/ADRD following military service and/or traumatic brain injury (TBI).  Research of interest may include, but is not limited to:

○         Identification and validation of biomarkers for diagnosis and prognosis of AD and ADRD:  including but not limited to fluid, tissues, imaging, device, and psychosocial, or a combination thereof.

○         Risk and resiliency factors for development of AD/ADRD during and after military service, such as genetic, physiological, psychosocial, and life history. 

○         Epidemiological studies examining TBI and/or military service-related factors, including TBI and AD/ADRD development.

• Fundamental research to better understand the etiology, risk, and comorbidities for AD/ADRD after TBI.

Funding Opportunities-FY22 PRARP, Congressionally Directed Medical Research Programs (CDMRP) (army.mil)

, NEW: Investigator-Initiated Research Award – Letter of Intent due June 17, 2022

Single Principal Investigator (PI) Option

Independent investigators at all academic levels (or equivalent).

Early-Career Investigator Partnering PI Option

The Early-Career Investigator PI must be an independent investigator within 10 years of their terminal degree by the time of the application submission deadline (excluding time spent in residence or on family medical leave) or new to the field

 Supports studies that will make important contributions to TBI and/or military-service-related factors as they pertain to AD/ADRD research, patient care, and quality of life.

 Clinical trials are NOT allowed.

 Community collaboration is required for projects involving clinical research.

 Applications must address at least one of the following FY22 PRARP Focus Areas:

– Individual, caregiver, and family support (animal studies are NOT allowed for this Focus Area)

– Diagnostic, environmental, and prognostic factors

– Foundational research

 The maximum allowable funding for the entire period of performance is $750,000 for total costs.

 Indirect costs may be proposed in accordance with the institution’s negotiated rate agreement.

 The maximum period of performance is 3 years.

NEW: Translational Research Award – Letter of Intent due June 17, 2022

Independent investigators at or above the level of Assistant Professor (or equivalent).

 Supports translational research that will accelerate the movement of promising products and knowledge in AD/ADRD research into clinical applications, including healthcare products and interventions, technologies, behavioral modalities, and/or clinical practice guidelines.

 Supports both preclinical-to-clinical and clinical research-to-clinical care translation.

 Clinical trials are NOT allowed.

 Preliminary data are required.

 Community collaboration is required for projects involving clinical research.

 Applications must address at least one of the following FY22 PRARP Focus Areas:

– Individual, caregiver, and family support (animal studies are NOT allowed for this Focus Area)

– Diagnostic, environmental, and prognostic factors

– Foundational research

• The maximum allowable funding for the entire period of performance is $750,000 for total costs.
• Indirect costs may be proposed in accordance with the institution’s negotiated rate agreement.
• The maximum period of performance Is 3 years.

Accelerating Diagnostics Research Award – Letter of Intent due June 17, 2022

Independent investigators at or above the level of Assistant Professor (or equivalent).

Supports high-impact advancement of robust diagnostic and/or prognostic factors pertaining to Alzheimer’s disease/Alzheimer’s disease-related dementias (AD/ADRD) following military service and/or traumatic brain injury (TBI).

 Studies are required to prospectively recruit study participants.

 Community collaboration is required.

 Preliminary data are required.

 Animal research is prohibited.

 Clinical trials are NOT allowed.

 Applications must address the following FY22 PRARP Focus Area:

– Diagnostic, environmental, and prognostic factors

 The maximum allowable funding for the entire period of performance is $2,500,000 for total costs.

 Indirect costs may be proposed in accordance with the institution’s negotiated rate agreement.

 The maximum period of performance is 4 years

A pre-application is required and must be submitted through the electronic Biomedical Research Application Portal (eBRAP) at https://eBRAP.org prior to the pre-application deadline.  All applications must conform to the final funding opportunity announcements available for downloading from the Grants.gov website.  The application package containing the required forms for each award mechanism will also be found on Grants.gov.  A listing of all CDMRP and other USAMRDC extramural funding opportunities can be obtained on the Grants.gov website by performing a basic search using CFDA Number 12.420. 

For email notification when announcements are released, subscribe to program-specific news and updates under “Email Subscriptions” on the eBRAP homepage at https://eBRAP.org.  For more information about the PRARP or other CDMRP-administered programs, please visit the CDMRP website (https://cdmrp.army.mil).

Point of Contact:

CDMRP Help Desk
301-682-5507
help@eBrap.org

For more information, please contact Jill Sherman, International Research Facilitator at intl.research@lakeheadu.ca.

This program is delivered in partnership with the Natural Sciences and Engineering Research Council of Canada (NSERC) and is an extension of the Idea to Innovation (I2I) Market Assessment Grant.

This 4-month program offers:

• Curriculum (lectures, talks, and workshops) designed to introduce researchers to the world of entrepreneurship.

• An advisor network (founders, industry leaders, and service providers) to help researchers through their business venture. 

• A community of like-minded entrepreneurs.

• $15,000 in funding to support researchers in getting their idea off the ground.

• The opportunity for future funding through the NSERC I2I Phase I grant. 

Applications close on June 27th, 2022.

If you have any questions or concerns, please feel free to reach out to our Learning & Recruitment Specialist, Wesley Kosiba, wkosiba@ryerson.ca.

The Burroughs Wellcome Fund Climate and Health Interdisciplinary Award provides support for collaborative exploratory work that opens new ground for comprehensively assessing or mitigating the impacts of climate change on human health. This program will support both individual scientists and multi-investigator teams. Early career faculty and postdoctoral fellows nearing their transition to independence are especially encouraged to apply, whether individually or within teams.

Our goal is to prime new discoveries in areas that are difficult to reach through discipline-specific, silo-driven approaches. Through this program, we will provide flexible funding for conceiving and piloting work that will grow into productive and informative collaborations among researchers approaching connected questions from fields that usually do not interact.

For more information, please contact Jill Sherman, International Research Facilitator, at intl.research@lakeheadu.ca.

The Burroughs Wellcome Fund aims to stimulate the growth of new connections between scholars working in largely disconnected fields who might together change the course of climate change’s impact on human health. Over the next two years, we will dedicate $1M to supporting small, early-stage grants of $2,500 - $50,000 toward achieving this goal.

Proposals will be accepted on a rolling basis through August 30, 2023. A review will be conducted quarterly. After each quarterly review, we will support, decline, or send proposals back to applicants for revision, but may hold some proposals over for a future review. Recommended revisions may include suggestions that separate groups of applicants submitting similar proposals work together to develop a single proposal or that applicants consider becoming involved in efforts aligned with work funded in earlier quarters.

For more information, please contact Jill Sherman, International Research Facilitator, at intl.research@lakeheadu.ca.

In this call for applications, we seek to support high-risk, high reward research projects and highly innovative and creative research ideas that have the potential to advance knowledge in neural development and neurodevelopmental disorders. This grant will provide seed funding for proposals that test new hypotheses, explore new approaches to intractable problems or challenge prevailing paradigms. We are looking for distinctive and novel approaches, including development of techniques or technologies that could enable new discoveries.

Supporting the next generation of brain researchers in Canada is needed to ensure the success of the Canadian brain research ecosystem. The Brain Canada Rising Stars Trainee Awards aim to recognize the excellent research being conducted at Canadian institutions by graduate students (M.Sc., Ph.D.), postdoctoral fellows, and residents in all fields spanning neuroscience research.

2022 Trainee Award Opportunities :

Shireen and Edna Marcus Excellence Award

• Purpose: To provide financial support to promising graduate students, postdoctoral fellows and/or residents conducting research in autism.
• Amount of award: $4,500 per award for one year, non-renewable.
• Number of awards: Up to 1 award.

Dr. Hubert van Tol Travel Fellowship

• Purpose: To allow graduate students (M.Sc., Ph.D.) and postdoctoral fellows to attend a major international conference/symposium or training course.
• Amount of award: $5,000 per one award, non-renewable.
• Number of awards: Up to 4 awards.

Canadian Consortium for the Investigation of Cannabinoids (CCIC) Neuroscience Fellowship in Cannabis and Cannabinoid Research

• Purpose: To provide financial support to graduate students (M.Sc., Ph.D.), postdoctoral fellows, or residents conducting neuroscience research at a Canadian institution in the field of cannabis/cannabinoid research.  
• Amount of award: $10,000 per award for one year, non-renewable.
• Number of awards: Up to 2 awards.

Dr. Matthew Galati Brain Changer Award

• Purpose: To provide financial support to graduate students (M.Sc., Ph.D.), postdoctoral fellows, or residents conducting clinical implementation research at a Canadian institution in the field of acquired brain injury.  
• Amount of award: $10,000 per award for one year, non-renewable.
• Number of awards: Up to 2 awards.

Evidence clearly shows that increasing equity, diversity, and inclusion (EDI) in research environments enhances excellence, innovation, and creativity. Brain Canada is committed to excellence through equity and encourages applicants of diverse backgrounds to apply to this funding opportunity, which will promote the expression of diverse perspectives, approaches, and experiences, including those of underrepresented groups.

For more information on the Brain Canada Rising Stars Trainee Awards, please consult the Request for Application. 

Deadline for receipt of Applications: June 2, 2022 at 16:00 ET

Should you have any questions, please contact programs@braincanada.ca